Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified Health Condition 2: J454- Moderate persistent asthma Health Condition 3: J453- Mild persistent asthma
Conditions
Interventions
Intervention1: A202 Compact Spacer Device: The compact spacer device will be kept attached to metered dose inhaler for 8 weeks and the usability will be assessed.
Control Intervention1: NA: NA
Sponsors
AeroDel Technology Innovations Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: For Asthma Adults aged 18 to 65 years For COPD 40 to 65 years age Participants willing to participate in the study Participants who are already using metered dose inhaler with spacer brands available in the market
Exclusion criteria
Exclusion criteria: Pregnant women and breastfeeding mothers Patients admitted with acute exacerbation of asthma or COPD Patients who are on nebulized medications Participants who have psychiatric illness or any other severe comorbid illness which may preclude participation in study Participants with an underlying end stage lung disease
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Compliance to metered dose inhaler with attached spacerTimepoint: Week 2 week 4 week 6 week 8 | — |
Primary
| Measure | Time frame |
|---|---|
| Patient comfort in using the device will be assessed based on responses to a structured questionnaireTimepoint: Patient comfort in using the device will be assessed fortnightly at 2nd, 4th, 6th and 8th week. | — |
Countries
India
Contacts
Public ContactDr Uma Maheswari K
St Johns Medical College
Outcome results
None listed